tinidazole has been researched along with Adnexitis in 3 studies
Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.
Adnexitis: Inflammation of the uterine appendages (ADNEXA UTERI) including infection of the FALLOPIAN TUBES (SALPINGITIS), the ovaries (OOPHORITIS), or the supporting ligaments (PARAMETRITIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred and sixty five women with diagnosis of pelvic inflammatory disease were randomized into three equal groups getting ciprofloxacin (500 mg) and tinidazole (600 mg) combination twice daily for 7 days (Group 1), a kit containing fluconazole (150 mg), azithromycin (1 gm) and secnidazole (2 mg) as one time dose (Group 2) and Doxycycline 100mg twice daily and metronidazole 200 mg thrice daily for seven days (Group 3)." | 9.10 | Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. ( Arora, R; Batra, S; Malhotra, M; Sharma, JB; Sharma, S, 2003) |
| "One hundred and sixty five women with diagnosis of pelvic inflammatory disease were randomized into three equal groups getting ciprofloxacin (500 mg) and tinidazole (600 mg) combination twice daily for 7 days (Group 1), a kit containing fluconazole (150 mg), azithromycin (1 gm) and secnidazole (2 mg) as one time dose (Group 2) and Doxycycline 100mg twice daily and metronidazole 200 mg thrice daily for seven days (Group 3)." | 5.10 | Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. ( Arora, R; Batra, S; Malhotra, M; Sharma, JB; Sharma, S, 2003) |
| "Urinary tract infections were found in 10 placebo (20." | 2.66 | Single-dose intravenous tinidazole prophylaxis in abdominal hysterectomy. ( Evaldson, GR; Lindgren, S; Malmborg, AS; Nord, CE, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, R | 1 |
| Zahra, F | 1 |
| Chandra, JA | 1 |
| Vatsal, P | 1 |
| Malhotra, M | 1 |
| Sharma, JB | 1 |
| Batra, S | 1 |
| Arora, R | 1 |
| Sharma, S | 1 |
| Evaldson, GR | 1 |
| Lindgren, S | 1 |
| Malmborg, AS | 1 |
| Nord, CE | 1 |
3 trials available for tinidazole and Adnexitis
| Article | Year |
|---|---|
A comparative study of injection placentrex and conventional therapy in treatment of pelvic inflammatory disease.
Topics: Abdominal Pain; Adnexal Diseases; Adult; Alkylating Agents; Anti-Bacterial Agents; Anti-Infective Ag | 2008 |
Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial.
Topics: Adolescent; Adult; Azithromycin; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Fluc | 2003 |
Single-dose intravenous tinidazole prophylaxis in abdominal hysterectomy.
Topics: Abscess; Adult; Aged; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Female; H | 1986 |